| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 06/09/2011 | US20110138493 BREEDING AND SELECTION FOR RESISTANCE TO MELON SEVERE MOSAIC VIRUS (MeSMV) |
| 06/09/2011 | US20110138492 Transgenic sugar beet plants |
| 06/09/2011 | US20110138491 Compositions and Method for Epigenetic Modification of Nucleic Acid Sequences in Vivo |
| 06/09/2011 | US20110138488 Deficiency in the histone demethylase jhdm2a results in impaired energy expenditure and obesity |
| 06/09/2011 | US20110137016 Compositions and methods for the diagnosis and treatment of tumor |
| 06/09/2011 | US20110137012 Cell culture method using amino acid-enriched medium |
| 06/09/2011 | US20110136922 Activation induced deaminase (aid) |
| 06/09/2011 | US20110136895 Methods and compositions for modulating PD1 |
| 06/09/2011 | US20110136892 Targeting TGF-beta as a Therapy for Alzheimer's Disease |
| 06/09/2011 | US20110136867 Treatment of Synucleinopathies |
| 06/09/2011 | US20110136813 Wnt protein signalling inhibitors |
| 06/09/2011 | US20110136781 Imidazotriazines and imidazopyrimidines as kinase inhibitors |
| 06/09/2011 | US20110136750 Compounds useful for treating neurodegenerative disorders |
| 06/09/2011 | US20110136749 Compounds useful for treating neurodegenerative disorders |
| 06/09/2011 | US20110136743 Survivin, a protein that inhibits cellular apoptosis, and its modulation |
| 06/09/2011 | US20110136689 Dual Expression Vector System for Antibody Expression in Bacterial and Mammalian Cells |
| 06/09/2011 | US20110136682 Antennary fucosylation in glycoproteins from cho cells |
| 06/09/2011 | US20110136681 Selection of stem cell clones with defined differentiation capabilities |
| 06/09/2011 | US20110136236 Genetically modified eukaryotic cells |
| 06/09/2011 | US20110136235 MK167 Mini-Promoters |
| 06/09/2011 | US20110136234 Cell culture substrate and its production method |
| 06/09/2011 | US20110136233 Nucleic acid compounds for inhibiting plk1 gene expression and uses thereof |
| 06/09/2011 | US20110136232 Anti-pyk2 antibodies |
| 06/09/2011 | US20110136231 Methods and use of inducing apoptosis in cancer cells |
| 06/09/2011 | US20110136230 Cultured Hematopoietic Stem Cells and Method for Expansion and Analysis Thereof |
| 06/09/2011 | US20110136229 Novel lectin |
| 06/09/2011 | US20110136228 Methods of cell culture for adoptive cell therapy |
| 06/09/2011 | US20110136227 Optimisation of expression of parvoviral rep and cap proteins in insect cells |
| 06/09/2011 | US20110136226 Stem cell bioprocessing and cell expansion |
| 06/09/2011 | US20110136225 Bioreactor, devices, systems and methods |
| 06/09/2011 | US20110136224 Mda-7 proteins and methods of use thereof |
| 06/09/2011 | US20110136223 Neurturin receptor |
| 06/09/2011 | US20110136222 Actuators for culturing and harvesting cells |
| 06/09/2011 | US20110136221 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities |
| 06/09/2011 | US20110136220 Method for Isolating Nuclei |
| 06/09/2011 | US20110136208 Antigen-specific regulatory t-cell induction |
| 06/09/2011 | US20110136203 Enzymatical modif ication of cell glycosylation using serum albumin and divalent cations |
| 06/09/2011 | US20110136184 Method for producing alpha-1, 6-branched alpha-1, 4-glucans from sucrose |
| 06/09/2011 | US20110136183 Method for producing alpha-1, 6-branched alpha-1, 4-glucans from sucrose |
| 06/09/2011 | US20110136172 Mammalian cytokines; related reagents |
| 06/09/2011 | US20110136171 Improved protein expression system |
| 06/09/2011 | US20110136169 Expression system compositions and methods |
| 06/09/2011 | US20110136148 Monoclonal Antibodies Against GMF-B Antigens, and Uses Therefor |
| 06/09/2011 | US20110136145 Methods for promoting fusion and reprogramming of somatic cells |
| 06/09/2011 | US20110136139 Method for enhancing transport of semiconductor nanocrystals across biological membranes |
| 06/09/2011 | US20110136119 AIMP2-DX2 Gene and its Uses |
| 06/09/2011 | US20110136114 Neural regenerating cells with alterations in dna methylation |
| 06/09/2011 | US20110136112 Identification of bitter ligands that specifically activate human t2r receptors and related assays for identifying human bitter taste modulators |
| 06/09/2011 | US20110136101 Immortalized Human Fetal Liver Cells |
| 06/09/2011 | US20110135707 Polyhydroxyalkanoates for in vivo applications |
| 06/09/2011 | US20110135696 Multipotent neural cells |
| 06/09/2011 | US20110135691 Immunomodulation by iap inhibitors |
| 06/09/2011 | US20110135689 Vaccine, therapeutic composition and methods for treating or inhibiting francisella tularenis |
| 06/09/2011 | US20110135688 Methods and Compositions for Increasing Titer of Recombinant Porcine Adenovirus-3 Vectors |
| 06/09/2011 | US20110135684 Use of L-alpha-lysophosphatidylcholine to obtain the differentiation of monocytes in mature dendritic cells in vitro |
| 06/09/2011 | US20110135677 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 06/09/2011 | US20110135675 Melanoma associated peptide analogues and vaccines against melanoma |
| 06/09/2011 | US20110135674 Markers of XMRV Infection and Uses Thereof |
| 06/09/2011 | US20110135672 Hla-g compositions and methods of use thereof |
| 06/09/2011 | US20110135666 Regulatory b cells and their uses |
| 06/09/2011 | US20110135662 FUNCTION MODIFYING NAv 1.7 ANTIBODIES |
| 06/09/2011 | US20110135659 Fish Vaccine |
| 06/09/2011 | US20110135658 Vhz for diagnosis and treatment of cancers |
| 06/09/2011 | US20110135657 Human antigen binding proteins that bind beta-klotho, fgf receptors and complexes thereof |
| 06/09/2011 | US20110135656 Method of treating cancer |
| 06/09/2011 | US20110135655 Role of PI3K p110 delta Signaling in Retroviral Infection and Replication |
| 06/09/2011 | US20110135653 Antibodies Against HER2 Truncated Variant CTF-611 |
| 06/09/2011 | US20110135649 Vascular Endothelial Growth Factor C (VEGF-C) Protein and Gene, Mutants Thereof, and Uses Thereof |
| 06/09/2011 | US20110135648 Anti-neublastin antibodies and uses thereof |
| 06/09/2011 | US20110135647 Genes and polypeptides relating to breast cancers |
| 06/09/2011 | US20110135643 Methods and compositions for prostate cancer immunotherapy |
| 06/09/2011 | US20110135635 Anti-alpha2 integrin antibodies and their uses |
| 06/09/2011 | US20110135634 Methods of inhibiting infection by diverse subtypes of drug-resistant hiv-1 |
| 06/09/2011 | US20110135633 Chronic lymphocytic leukemia cell line |
| 06/09/2011 | US20110135630 Chemical modification of antibody fragments |
| 06/09/2011 | US20110135629 EYA2S As Modifiers of the PTEN/AKT Pathway and Methods of Use |
| 06/09/2011 | US20110135620 Prodrug activation in cancer cells using molecular switches |
| 06/09/2011 | US20110135617 Pairing processes for preparing reactive cytotoxic T cells |
| 06/09/2011 | US20110135613 Methods for treating apolipoprotein e4-associated disorders |
| 06/09/2011 | US20110135612 Compositions to effect neuronal growth |
| 06/09/2011 | US20110135610 Multipotent stem cells from the extrahepatic biliary tree and methods of isolating same |
| 06/09/2011 | US20110135607 Viral nucleic acid for the treatment of neurodegenerative disorders |
| 06/09/2011 | US20110135606 Test systems for the analysis of polypeptides and cells adhering to silicones |
| 06/09/2011 | US20110135596 Fusion protein comprising ubiquitin or ubiquitin-like protein, membrane translocation sequence and biologically active molecule and use thereof |
| 06/09/2011 | US20110135575 Metalloprotein mri contrast agents and related methods |
| 06/09/2011 | US20110135571 Hybrid nanoparticles as anti-cancer therapeutic agents and dual therapeutic/imaging contrast agents |
| 06/09/2011 | US20110135570 Anti-Tumor Cell Antigen Antibody Therapeutics |
| 06/09/2011 | CA2782596A1 Method for constructing chimeric rat using rat embryonic stem cells |
| 06/09/2011 | CA2782577A1 Selection of stem cell clones with defined differentiation capabilities |
| 06/09/2011 | CA2782296A1 Formulations and methods for culturing stem cells |
| 06/09/2011 | CA2782290A1 Expression cassettes for embryo-specific expression in plants |
| 06/09/2011 | CA2782013A1 Large scale generation of functional megakaryocytes and platelets from human embryonic stem cells under stromal-free conditions |
| 06/09/2011 | CA2781969A1 Method of generating natural killer cells and dendritic cells from human embryonic stem cell-derived hemangioblasts |
| 06/09/2011 | CA2781655A1 Sweet taste receptor-expressing construct, cell body expressing the same, and utilization thereof |
| 06/08/2011 | EP2330213A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 06/08/2011 | EP2330207A2 Transgenic plant-based methods for plant pests using RNAi |
| 06/08/2011 | EP2330203A2 Rna constructs |
| 06/08/2011 | EP2330200A2 Gene expression technique |
| 06/08/2011 | EP2330198A1 IL-1 related polypeptides |
| 06/08/2011 | EP2330197A2 Antagonistic selective binding agents of osteoprotegerin binding protein |